Cart summary

You have no items in your shopping cart.

RNA binder 2

SKU: orb3135261

Description

RNA binder 2 (Compound 20) serves as a covalent inhibitor of r(CUG)expRNA in myotonic dystrophy type 1 (DM1). It attaches to RNA through the Hoechst scaffold, hindering the binding of MBNL1 and reinstating the normal splicing process. This compound holds potential for research in the context of myotonic dystrophy type 1.

Images & Validation

Key Properties

TargetDNA/RNA Synthesis

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Covidcil-19 [orb1738289]

    1225177-95-6

    294.31

    C16H14N4O2

    10 mg, 50 mg
  • ARL2BP siRNA (Rat) [orb1827374]

    RNA-I

    15 nmol, 30 nmol
  • MOB2 siRNA (Mouse) [orb1838764]

    RNA-I

    15 nmol, 30 nmol
  • CDC42EP2 siRNA (Mouse) [orb1838630]

    RNA-I

    15 nmol, 30 nmol
  • CDC42EP2 siRNA (Rat) [orb1828721]

    RNA-I

    15 nmol, 30 nmol
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

RNA binder 2 (orb3135261)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%